THE FIRST CASE OF COMPOSITE HEMANGIOENDOTHELIOMA WITH NEUROENDOCRINE DIFFERENTIATION IN THE ADRENAL GLAND: 1,5 YEAR FOLLOW-UP AFTER PRONE RETROPERITONEOSCOPIC RESECTION

AUTHORS:
A. Kechagias (Athens, Greece) , G. Kirkilesis (Athens, Greece) , C. Masaoutis (Athens, Greece) , N. Kritikos (Athens, Greece)
Background:
Composite Hemangioendothelioma (CH) is an extremely rare vascular neoplasm which develops predominantly in the skin, soft-tissue, and musculoskeletal system. Very few cases have been described in viscera (kidney, spleen), but never in the adrenal. CH is thought to have an intermediate biological potential, with benign, low-grade malignant, and malignant vascular components. An even more rare (and more aggressive) subtype of CH is this with neuroendocrine differentiation (CH-ND). To the best of our knowledge we present the first reported case of an adrenal CH-ND with a follow-up of 1,5 year after complete resection with the posterior retroperitoneoscopic procedure.
Methods:
A 39-year old otherwise healthy woman was referred due to an 8.7 cm mixed mass of the left adrenal with multiple cystic and solid components in the computed-tomography scan (pictures shown). She underwent a complete left adrenal gland removal with the 3-keyhole prone retroperitoneoscopic approach. We present the Operative Video which shows the complete resection of the mass. The patient was discharged the day after surgery.
Results:
Pathology showed an adrenal CH of the neuroendocrine subtype, characterized by a diffuse expression of endothelial markers. The Ki67 index was low (2%). Histology pictures are provided. The case was discussed in the oncological multidisciplinary meeting and a 6-month follow-up with imaging was decided. At 1,5 year of follow-up there are not any findings of recurrence or of metastasis.
Conclusions:
This is the first described case of an adrenal CH-ND. The complete and oncologic removal of a large (>8.5cm) CH is feasible with the minimally invasive posterior retroperitoneoscopy.